Waypoint Bio
Waypoint Bio is a venture-backed biotech startup building the next generation of cancer therapies. Our platform combines “spatial pooled screening” technology with machine learning to build breakthrough therapies that we believe can meaningfully improve patients’ lives. We are a highly collaborative, interdisciplinary team that moves quickly to bring promising therapies to patients faster.
CORE INFO
Waypoint Bio is a biotechnology company that develops advanced cell therapies for solid tumors using a proprietary platform that integrates AI and machine learning to optimize CAR T-cell therapies.
- Series A funding round raised $20 million, led by Amplify Partners, with participation from General Catalyst, Time BioVentures, Mitsui Global Investments, and Lux Capital.businesswire.com
- Business Wire reported on Waypoint Bio's Series A funding, highlighting the company's plans to advance AI-designed cell therapies toward clinical application.businesswire.com
WHY WE WOULD WORK AT WAYPOINT BIO
Impactful Mission
Join a team dedicated to developing next-gen cell therapies for solid tumors, making a real difference in the lives of cancer patients.
Innovative Technology
Work with cutting-edge spatial pooled screening technology and AI/ML to optimize CAR T-cell therapies, pushing the boundaries of biotechnology.
Diverse Expertise
Collaborate with a talented team of experts in spatial biology, computational biology, and genomics, fostering a rich environment for learning and innovation.
Competitive Funding
Be part of a well-funded venture-backed startup, having raised $20M in Series A funding to accelerate the development of groundbreaking therapies.
Recognition and Growth
Benefit from the leadership of pioneers like Dr. Patrick Kaifosh, enhancing your career in a rapidly evolving field with significant growth potential.
Creative Problem Solving
Engage in high-throughput testing of thousands of therapies, utilizing AI-driven insights to tackle complex challenges in cancer treatment.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
GROWTH TACTICS
KEY METRICS
✦ KEY METRICCOMPETITIVE ADVANTAGE
NOTABLE CUSTOMERS
PRODUCT AND TECH
Spatial Pooled Screening
Waypoint Bio utilizes spatial pooled screening technology to conduct high-throughput testing of thousands of potential CAR T-cell therapies within a single model, enabling the measurement of hundreds of phenotypes at the single-cell level.
AI-Driven Therapy Design
The company leverages artificial intelligence and machine learning to design and optimize chimeric antigen receptor (CAR) T-cell therapies, accelerating the discovery of effective treatments for solid tumors.
High-Throughput Testing
Waypoint Bio's platform allows for rapid evaluation of multiple therapy candidates simultaneously, significantly speeding up the development process for new cell therapies aimed at complex diseases like cancer.
In Vivo Model Integration
By integrating their technologies within in vivo models, Waypoint Bio can assess the real-time efficacy of cell therapies, ensuring that their designs are both innovative and clinically relevant.
Expert Scientific Advisory Board
The company has assembled a diverse Scientific Advisory Board with expertise in spatial biology, computational biology, and genomics, providing strategic guidance to enhance their cell therapy development efforts.